The Correlation Between Central Conduction Time and Central Pain Syndrome in Chronic Neck Pain

July 7, 2026 updated by: Salah Eid Ahmed Ali, Cairo University
To investigate the neurophysiological relationship between Central Conduction Time measured via Somatosensory evoked potentials and pain intensity in individuals suffering from chronic neck pain

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

The explicit lack of direct studies linking Central conduction time to Central pain syndrome in Chronic neck pain, coupled with strong evidence for central sensitization as a key mechanism in CNP and the defining characteristic of CPS, points to a significant diagnostic gap. Somatosensory evoked potential serves as a valuable neurophysiological marker for the structural integrity and conduction velocity of central neural pathways, its direct relationship to the functional dysregulation seen in central pain syndrome in the context of chronic neck pain has not been explicitly established.

Study Type

Observational

Enrollment (Estimated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Salah Eid Ahmed Ali, Assistant Lecturer
  • Phone Number: +201158125773
  • Email: salaheid07@gmail.com

Study Locations

      • Cairo, Egypt
        • Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Participants aged 18-35 years, with normal Body Mass Index (BMI) of less than 25 kg/m2, including both genders were included.

Description

Inclusion Criteria:

  • Participants aged 18-35 years.
  • Normal Body Mass Index (BMI) less than 25 kg/m2.
  • Both genders were included.
  • having chronic neck pain lasting for more than three months.

Exclusion Criteria:

  • signs of serious pathology (e.g., malignancy, inflammatory disorders, infection).
  • history of cervical spine surgery.
  • history of trauma or fractures in the cervical spine.
  • presence of vascular syndromes such as vertebrobasilar insufficiency.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic Neck Pain
Time Frame: at the begining of assessment
Chronic Neck Pain measured using visual analogue scale
at the begining of assessment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Central Conduction Time
Time Frame: at the begining of assessment only.
Central Conduction Time measured in milliseconds using Electromyography device (Neuro-EMG-Micro/4, Neurosoft, Russia)
at the begining of assessment only.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 10, 2026

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

July 7, 2026

First Submitted That Met QC Criteria

July 7, 2026

First Posted (Actual)

July 13, 2026

Study Record Updates

Last Update Posted (Actual)

July 13, 2026

Last Update Submitted That Met QC Criteria

July 7, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/005992.

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Neck Pain

3
Subscribe